The application of PET to quality assurance of heavy-ion tumor therapy.
At the new heavy ion tumor therapy facility of the Gesellschaft für Schwerionenforschung at Darmstadt positron emission tomography (PET) has been implemented for in-beam and in-situ therapy control, i.e. during the tumor irradiation. The components necessary for this dedicated PET-imaging and their integration into the framework of therapy planning and quality assurance of heavy ion cancer treatments are presented. Results of the first application of this PET-method to patient treatments are reported.
Enghardt
W
W
Forschungszentrum Rossendorf, Institut für Kern- und Hadronenphysik, Dresden. W.Enghardt@fz-rossendorf.de
Debus
J
J
Haberer
T
T
Hasch
B G
BG
Hinz
R
R
Jäkel
O
O
Krämer
M
M
Lauckner
K
K
Pawelke
J
J
D005858:Germany; D006801:Humans; D007091:Image Processing, Computer-Assisted; D009010:Monte Carlo Method; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy*; D019047:Phantoms, Imaging; D011785:Quality Assurance, Health Care; D011881:Radiotherapy, Computer-Assisted / Q000295:instrumentation / Q000379:methods*; D011882:Radiotherapy, High-Energy / Q000295:instrumentation / Q000379:methods / Q000592:standards; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed